How pharma can productively coexist with PBMs—and still lower drug costs faster.
Mark Thierer, EVERSANA
Advertisement
CEO of EVERSANA
Articles by Mark Thierer, EVERSANA
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
From Launch to Loss of Exclusivity: Reducing Access and Affordability Barriers Across the Brand Lifecycle
2
CMS Announces Selection of Drugs for Third Cycle of Medicare Drug Price Negotiation Program, Including First-Ever Part B Drugs
3
Morris & Dickson Acquires Prodigy Health to Expand Specialty and Plasma Distribution Capabilities
4
Why Trust Is the Biggest Barrier to Supply Chain Transparency
5